PTAB Has To Eye Hormone Drug Fight Again, Vidal Finds
The director of the U.S. Patent and Trademark Office on Friday reversed a Patent Trial and Appeal Board decision that refused to reassess a biotechnology maker's patent related to the treatment...To view the full article, register now.
Already a subscriber? Click here to view full article